Distinct inactive conformations of the dopamine D2 and D3 receptors correspond to different extents of inverse agonism.

Lane, J Robert; Abramyan, Ara M; Adhikari, Pramisha; Keen, Alastair C; Lee, Kuo-Hao; Sanchez, Julie; Verma, Ravi Kumar; Lim, Herman D et al. · Elife · 2020

basic_science · Level V

Where this comes from

Abstract

By analyzing and simulating inactive conformations of the highly homologous dopamine D<sub>2</sub> and D<sub>3</sub> receptors (D<sub>2</sub>R and D<sub>3</sub>R), we find that eticlopride binds D<sub>2</sub>R in a pose very similar to that in the D<sub>3</sub>R/eticlopride structure but incompatible with the D<sub>2</sub>R/risperidone structure. In addition, risperidone occupies a sub-pocket near the Na<sup>+</sup> binding site, whereas eticlopride does not. Based on these findings and our experimental results, we propose that the divergent receptor conformations stabilized by Na<sup>+</sup>-sensitive eticlopride and Na<sup>+</sup>-insensitive risperidone correspond to different degrees of inverse agonism. Moreover, our simulations reveal that the extracellular loops are highly dynamic, with spontaneous transitions of extracellular loop 2 from the helical conformation in the D<sub>2</sub>R/risperidone structure to an extended conformation similar to that in the D<sub>3</sub>R/eticlopride structure. Our results reveal previously unappreciated diversity and dynamics in the inactive conformations of D<sub>2</sub>R. These findings are critical for rational drug discovery, as limiting a virtual screen to a single conformation will miss relevant ligands.

Medical subject headings